Vascular Endothelial Growth Factor and Angiogenesis

By A. Hoeben, B. Landuyt, M. Highley, H. Wildiers, A. V. van Oosterom, E. D. de Bruijn. Pharmacological Reviews, 2004

1,932 citations recorded by the source corpus.

Subfields: Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/3df15ca287f1e3fd34fc328607e9f6ba7e62ee74

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. B. Olsen
2. Kai Hu
3. Young-Woong Kim
4. R. Roskoski
5. T. Byzova

In Oncology

1. B. Olsen
2. Kai Hu
3. R. Roskoski

Citations in the corpus

• Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis. (2018, background): “Binding VEGF to VEGFR-2 stimulates the secretion of von Willebrand factor (vWF) by endothelial cells [33, 52]; the activation of endothelial cells is an essential event for tumor progression [52].”
• Angiogenic and cell survival functions of Vascular Endothelial Growth Factor (VEGF) (2005, background): “In addition to endothelial cells, VEGF also stimulates migration of vascular smooth muscle cells, monocytes, mononuclear phagocytes and polymorphonuclear cells [8, 26] and migration and invasion of some tumour cells such as breast and leukemia.”
• Oxidative stress in angiogenesis and vascular disease. (2014, background): “New blood vessel formation is essentially required for many physiological processes, such as embryogenesis, tissue repair, and organ regeneration.(1) This process, however, needs to be finely balanced, because excessive or insufficient angiogenesis contributes to a number of pathologies, ranging fro”
• The roles of vascular endothelial growth factor in bone repair and regeneration (2016, background): “VEGF functions not only as one of the most important regulators of vascular development and angiogenesis [6, 7], it also plays critical roles in skeletal development [8-10].”
• Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy (2017, background): “Prostaglandin E (PGE2) is synthesised from arachidonic acid by cyclooxygenase (COX)-2, which regulates VEGF expression [45].”
• Vascular endothelial growth factor (VEGF) signaling in tumor progression. (2007, background): “[29] Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT,”